Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes
暂无分享,去创建一个
T. Greenhalgh | G. Bevan | M. Airoldi | D. Craig | E. Barry | S. Roberts
[1] G. Lenon,et al. Psychometric Evaluation of the Revised Michigan Diabetes Knowledge Test (V.2016) in Arabic: Translation and Validation , 2016, Journal of diabetes research.
[2] K. Khunti,et al. A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial. , 2016, Preventive medicine.
[3] H. Delisle,et al. Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation Studies , 2016, Journal of diabetes research.
[4] N. Pronk,et al. A systematic review of real-world diabetes prevention programs: learnings from the last 15 years , 2015, Implementation Science.
[5] N. Daniels,et al. Expanded HTA: Enhancing Fairness and Legitimacy. , 2015, International journal of health policy and management.
[6] L. Curtis,et al. Unit Costs of Health and Social Care 2016 , 2015 .
[7] P. Remington,et al. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force , 2015, Annals of Internal Medicine.
[8] E. Gregg,et al. Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force , 2015, Annals of Internal Medicine.
[9] K. A. Al-Ghamdi,et al. CorrigendumCorrigendum to: “Threshold tool-radius condition maximizing the formability in SPIF considering a variety of materials: Experimental and FE investigations” [Int. J. Mach. Tools Manuf. 88 (2015) 82–94] , 2015 .
[10] Michael J. O'Grady,et al. Value of lifestyle intervention to prevent diabetes and sequelae. , 2015, American journal of preventive medicine.
[11] S. Fowler,et al. HbA1c as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial , 2014, Diabetes Care.
[12] J. Yoong,et al. Evaluating the Cost-Effectiveness of Lifestyle Modification versus Metformin Therapy for the Prevention of Diabetes in Singapore , 2014, PloS one.
[13] R. Wheeler,et al. The epidemic of pre-diabetes: the medicine and the politics , 2014, BDJ.
[14] R. Kahn,et al. The Reality of Type 2 Diabetes Prevention , 2014, Diabetes Care.
[15] Andrew H Briggs,et al. Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[16] Anne Douglas,et al. Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. , 2014, The lancet. Diabetes & endocrinology.
[17] O. Solà-Morales,et al. Lifestyle interventions for diabetes mellitus type 2 prevention. , 2014, Revista clinica espanola.
[18] O. Solà-Morales,et al. Coste-efectividad de la intervención sobre el estilo de vida para prevenir la diabetes tipo 2 , 2014 .
[19] The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012;35:723–730 , 2013, Diabetes Care.
[20] C. Toumazou,et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. , 2013, The lancet. Diabetes & endocrinology.
[21] I. Feldman,et al. Heterogeneity in cost-effectiveness of lifestyle counseling for metabolic syndrome risk groups -primary care patients in Sweden , 2013, Cost Effectiveness and Resource Allocation.
[22] Changping Li,et al. An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study , 2013, BMC Public Health.
[23] T. Vos,et al. The role of cost-effectiveness analysis in developing nutrition policy. , 2013, Annual review of nutrition.
[24] Paul D P Pharoah,et al. Cost effectiveness of the NHS breast screening programme: life table model , 2013, BMJ.
[25] K. Khunti,et al. Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis , 2013, Diabetologia.
[26] J. Katula,et al. The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial. , 2013, American journal of preventive medicine.
[27] Morton B. Brown,et al. Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. , 2013, The American journal of managed care.
[28] Jianqin Sun,et al. Effects of lifestyle intervention and meal replacement on glycaemic and body-weight control in Chinese subjects with impaired glucose regulation: a 1-year randomised controlled trial. , 2013, The British journal of nutrition.
[29] A J Palmer,et al. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis. , 2012, Primary care diabetes.
[30] Alaa Badawi,et al. Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation , 2012, ClinicoEconomics and outcomes research : CEOR.
[31] Ping Zhang,et al. The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention , 2012, Diabetes Care.
[32] O. Solà-Morales,et al. Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention , 2012, Diabetologia.
[33] G. Reed,et al. Outcomes of a Latino community-based intervention for the prevention of diabetes: the Lawrence Latino Diabetes Prevention Project. , 2012, American journal of public health.
[34] V. Basevi,et al. Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.
[35] Trisha Greenhalgh,et al. Risk models and scores for type 2 diabetes: systematic review , 2011, BMJ : British Medical Journal.
[36] P. Schwarz,et al. Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling , 2011, Cost effectiveness and resource allocation : C/E.
[37] M. Sampson,et al. Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes , 2011, International Journal of Technology Assessment in Health Care.
[38] P. Vermunt,et al. Lifestyle Counseling for Type 2 Diabetes Risk Reduction in Dutch Primary Care , 2011, Diabetes Care.
[39] Makoto Watanabe,et al. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. , 2011, Archives of internal medicine.
[40] K. Kotani,et al. Prevention of type 2 diabetes in a primary healthcare setting: Three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance , 2011, BMC public health.
[41] Kenneth J. Smith,et al. Cost-Effectiveness Analysis of Efforts to Reduce Risk of Type 2 Diabetes and Cardiovascular Disease in Southwestern Pennsylvania, 2005-2007 , 2010, Preventing chronic disease.
[42] U. Gerdtham,et al. Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases , 2010, International journal of environmental research and public health.
[43] Ping Zhang,et al. Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review , 2010, Diabetes Care.
[44] Carol R Horowitz,et al. Results of a pilot diabetes prevention intervention in East Harlem, New York City: Project HEED. , 2010, American journal of public health.
[45] Stephen S. Lim,et al. Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care , 2010, Diabetologia.
[46] D. Nathan,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[47] M. Walker,et al. Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK , 2009, BMC public health.
[48] K. Khunti,et al. Effectiveness of a Pragmatic Education Program Designed to Promote Walking Activity in Individuals With Impaired Glucose Tolerance , 2009, Diabetes Care.
[49] J. Holst,et al. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? , 2009, Diabetologia.
[50] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[51] W. Saris,et al. Impact of 3‐year lifestyle intervention on postprandial glucose metabolism: the SLIM study , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[52] Jaroslaw Wechowski. Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults , 2008, Diabetes Care.
[53] Nicola J Cooper,et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis , 2008, BMJ : British Medical Journal.
[54] S. Grosse. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold , 2008, Expert review of pharmacoeconomics & outcomes research.
[55] S. Hunter,et al. Dietary carbohydrate does not pose an additional metabolic challenge, a response to Alberti et al. IDF: a consensus on type 2 diabetes prevention , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[56] Ambady Ramachandran,et al. Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians , 2007, Diabetes Care.
[57] M. Aalabaf-Sabaghi. Decision modelling for health economic evaluation , 2007, Journal of Epidemiology and Community Health.
[58] P Zimmet,et al. International Diabetes Federation: a consensus on Type 2 diabetes prevention , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[59] R. Holle,et al. Clinical and cost‐effectiveness of primary prevention of Type 2 diabetes in a ‘real world’ routine healthcare setting: model based on the KORA Survey 2000 , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[60] Peter Lindgren,et al. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective , 2007, International Journal of Technology Assessment in Health Care.
[61] R. Hoogenveen,et al. Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk , 2007, Diabetes Care.
[62] K. Alberti,et al. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. , 2006, Diabetes research and clinical practice.
[63] David V. Power,et al. Standards of Medical Care in Diabetes: Response to position statement of the American Diabetes Association , 2006 .
[64] C. Snehalatha,et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) , 2006, Diabetologia.
[65] A. Krikorian,et al. Standards of medical care in diabetes--2006. , 2006, Diabetes care.
[66] David M Eddy,et al. Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes , 2005, Annals of Internal Medicine.
[67] K. Kosaka,et al. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. , 2005, Diabetes research and clinical practice.
[68] F. Pang,et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. , 2004, Health technology assessment.
[69] J. Caro,et al. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[70] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[71] David Parkin,et al. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. , 2004, Health economics.
[72] J. Shaw,et al. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. , 2004, Clinical therapeutics.
[73] Jaakko Tuomilehto,et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. , 2003, Diabetes care.
[74] J. Sachs. Macroeconomics and health: investing in health for economic development , 2002 .
[75] C. Currie,et al. The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060 , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[76] A. Ivinson. Macroeconomics and Health: Investing in Health for Economic Development , 2002, Nature Medicine.
[77] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[78] R. Fitzpatrick,et al. Patient‐assessed health outcome measures for diabetes: a structured review , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[79] J. Shaw,et al. Global and societal implications of the diabetes epidemic , 2001, Nature.
[80] B. Howard,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.
[81] K. Eriksson,et al. Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malmö feasibility study , 1991, Diabetologia.
[82] K. Khuntia,et al. Progression rates from HbA 1 c 6 . 0-6 . 4 % and other prediabetes definitions to type 2 diabetes : A meta-analysis , 2017 .
[83] Type 2 diabetes: prevention in people at high risk , 2017 .
[84] S. Boccia,et al. A systematic review of the cost-effectiveness of lifestyle modification as primary prevention intervention for diabetes mellitus type 2 , 2013 .
[85] D. Williamson,et al. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? , 2012, Health affairs.
[86] L. Barker,et al. A nationwide community-based lifestyle program could delay or prevent type 2 diabetes cases and save $5.7 billion in 25 years. , 2012, Health affairs.
[87] T. Schaufler,et al. Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany , 2010, Applied health economics and health policy.
[88] S. Colagiuri,et al. Using an economic model of diabetes to evaluate prevention and care strategies in Australia. , 2008, Health affairs.
[89] B. Robberstad. QALYs vs DALYs vs LYs gained: What are the differences, and what difference do they make for health care priority setting? , 2005 .
[90] C. Normand,et al. A systematic review of the role of bisphosphonates in metastatic disease. , 2004, Health technology assessment.
[91] D. Quinton,et al. Unit Costs of Health and Social Care 2004 , 2004 .
[92] The National Institute for Clinical Excellence. , 2001, Nursing management.
[93] T. J. Berg. [Can type 2 diabetes be prevented?]. , 2000, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[94] P. Lavori,et al. Translating the Diabetes Prevention Program Lifestyle Intervention for Weight Loss into Primary Care a Randomized Trial , 2022 .
[95] Dang Qing,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The , 2022 .